![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, November 22, 2017 10:45:56 AM
ISODIOL INTERNATIONAL INC. SIGNS DEFINITIVE AGREEMENT TO ACQUIRE BRADLEY'S BIOSCIENCE INC., AND CLOSES STRATEGIC FINANCING
Isodiol International Inc. has entered into a definitive agreement in connection with its previously announced letter of intent to acquire Bradley's Bioscience Inc., a leading manufacturer and distributer of hemp oil and nicotine e-liquids.
"The acquisition of Bradley's Bioscience, a market poised to be a $61.4-billion industry by 2025 is another major milestone for the company," said Marcos Agramont, chief executive officer of Isodiol. "Not only does this allow the company to penetrate a new market, but we are now also able to provide consumers with a safer alternative to smoking. Over all, we believe Bradley's Bioscience is a perfect fit with Isodiol and our long-term vision and we are very pleased to be moving forward with this agreement."
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM